These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18272197)

  • 1. Factors involved in the maturation of murine dendritic cells transduced with adenoviral vector variants.
    Kanagawa N; Koretomo R; Murakami S; Sakurai F; Mizuguchi H; Nakagawa S; Fujita T; Yamamoto A; Okada N
    Virology; 2008 May; 374(2):411-20. PubMed ID: 18272197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.
    Tillman BW; Hayes TL; DeGruijl TD; Douglas JT; Curiel DT
    Cancer Res; 2000 Oct; 60(19):5456-63. PubMed ID: 11034088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis.
    Oberholzer A; Oberholzer C; Efron PA; Scumpia PO; Uchida T; Bahjat K; Ungaro R; Tannahill CL; Murday M; Bahjat FR; Tsai V; Hutchins B; Moldawer LL; Laface D; Clare-Salzler MJ
    Shock; 2005 Jun; 23(6):507-15. PubMed ID: 15897802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological properties and vaccine efficacy of murine dendritic cells simultaneously expressing melanoma-associated antigen and interleukin-12.
    Okada N; Iiyama S; Okada Y; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
    Cancer Gene Ther; 2005 Jan; 12(1):72-83. PubMed ID: 15389286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective transduction of dendritic cells in human lymph nodes and superior induction of high-avidity melanoma-reactive cytotoxic T cells by a CD40-targeted adenovirus.
    Hangalapura BN; Oosterhoff D; Aggarwal S; Wijnands PG; van de Ven R; Santegoets SJ; van den Tol MP; Hooijberg E; Pereboev A; van den Eertwegh AJ; Curiel DT; Scheper RJ; de Gruijl TD
    J Immunother; 2010 Sep; 33(7):706-15. PubMed ID: 20664356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction.
    Okada N; Mori N; Koretomo R; Okada Y; Nakayama T; Yoshie O; Mizuguchi H; Hayakawa T; Nakagawa S; Mayumi T; Fujita T; Yamamoto A
    Gene Ther; 2005 Jan; 12(2):129-39. PubMed ID: 15483669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors.
    Okada N; Masunaga Y; Okada Y; Iiyama S; Mori N; Tsuda T; Matsubara A; Mizuguchi H; Hayakawa T; Fujita T; Yamamoto A
    Cancer Gene Ther; 2003 May; 10(5):421-31. PubMed ID: 12719712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
    Yurkovetsky ZR; Shurin GV; Barry DA; Schuh AC; Shurin MR; Robbins PD
    J Gene Med; 2006 Feb; 8(2):129-37. PubMed ID: 16288496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC.
    van Leeuwen EB; Cloosen S; Senden-Gijsbers BL; Germeraad WT; Bos GM
    Cytotherapy; 2006; 8(1):36-46. PubMed ID: 16627343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors.
    Okada N; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Saito T; Fujita T; Yamamoto A; Hayakawa T; Mayumi T
    Biochem Biophys Res Commun; 2001 Mar; 282(1):173-9. PubMed ID: 11263988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.
    Perreau M; Mennechet F; Serratrice N; Glasgow JN; Curiel DT; Wodrich H; Kremer EJ
    J Virol; 2007 Apr; 81(7):3272-84. PubMed ID: 17229706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [In vivo migration and survival of donor-derived dendritic cell progenitors genetically modified using an adenoviral vector encoding cDNA for TGF beta 1].
    Zhong C; Li WZ; Lü L
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):174-7. PubMed ID: 11601033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coxsackievirus-adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells.
    Pereboev AV; Asiedu CK; Kawakami Y; Dong SS; Blackwell JL; Kashentseva EA; Triozzi PL; Aldrich WA; Curiel DT; Thomas JM; Dmitriev IP
    Gene Ther; 2002 Sep; 9(17):1189-93. PubMed ID: 12170383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization to enhanced green fluorescence protein minor histocompatibility antigen by gene transduction into dendritic cells and peritoneal exudate macrophages.
    Satoh E; Li XK; Hara Y; Ogata K; Guo L; Kitazawa Y; Funeshima-Fuji N; Satoh T; Miyagi T; Sugiura W; Yamamoto N; Teramoto K; Arii S; Kimura H
    Transpl Immunol; 2007 Nov; 18(2):73-84. PubMed ID: 18005848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53.
    Nikitina EY; Chada S; Muro-Cacho C; Fang B; Zhang R; Roth JA; Gabrilovich DI
    Gene Ther; 2002 Mar; 9(5):345-52. PubMed ID: 11938454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: optimized design and procedures for highly efficient transduction compatible with clinical constraints.
    Rouas R; Uch R; Cleuter Y; Jordier F; Bagnis C; Mannoni P; Lewalle P; Martiat P; Van den Broeke A
    Cancer Gene Ther; 2002 Sep; 9(9):715-24. PubMed ID: 12189521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine dendritic cells infected with adenovirus vectors show signs of activation.
    Hirschowitz EA; Weaver JD; Hidalgo GE; Doherty DE
    Gene Ther; 2000 Jul; 7(13):1112-20. PubMed ID: 10918477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector.
    Tillman BW; de Gruijl TD; Luykx-de Bakker SA; Scheper RJ; Pinedo HM; Curiel TJ; Gerritsen WR; Curiel DT
    J Immunol; 1999 Jun; 162(11):6378-83. PubMed ID: 10352250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.